Methylation status of the long control region of HPV 16 in clinical cervical specimens

  • Authors:
    • Die Hong
    • Feng Ye
    • Weiguo Lu
    • Ying Hu
    • Xiaoyun Wan
    • Yaxia Chen
    • Xing Xie
  • View Affiliations

  • Published online on: July 1, 2008     https://doi.org/10.3892/mmr.1.4.555
  • Pages: 555-560
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

DNA methylation is one of the regulatory pathways that modulate human papillomavirus (HPV) gene expression. To obtain detailed methylation information on crucial areas of the long control region (LCR) of HPV 16 and to clarify the significance of methylation in clinical cervical lesions, 80 clinical samples were examined to determine the methylation status of the HPV 16 promoter and enhancer core using bisulfite modification and pyrosequencing. Seventy samples [26 of cervical carcinoma (CC), 13 of cervical intraepithelia neoplasia (CIN) III, 17 of CIN I-II and 14 of asymptomatic HPV 16 infection] were successfully examined. Analysis of the general methylation status of HPV 16 LCR in the 70 clinical specimens revealed 43 (61.4%) with methylation in the promoter and/or enhancer core of HPV 16. The proportion of methylated samples was highest in CC specimens (84.6%), followed by asymptomatic infection (71.4%) and CIN III (46.2%), while the proportion of methylated samples was lowest in CIN I-II specimens (29.4%). The methylation status of eight CpGs in HPV 16 LCR was determined in detail. In general, the methylation of CpGs was more common in the promoter than in the enhancer core region. The methylation frequencies of the eight CpGs ranged from 14.6±7.2 to 33.7±23.0% in individual methylated CpG cases. The methylation pattern of all eight CpGs methylated in the promoter and enhancer core was more common in CC, and the pattern of scattered methylated CpGs was relatively more prevalent in asymptomatic infections. Our study demonstrates that DNA methylation is a common phenomenon in HPV 16 LCR clinical specimens, and may function as a host defense mechanism. While hypomethylation is probably associated with the initiation of neoplasia, hypermethylation in cervical cancer may be a reflection of the host defense mechanism. In the regulation of transcription, methylation is of more importance in the HPV 16 promoter than in the enhancer core.

Related Articles

Journal Cover

July-August 2008
Volume 1 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Hong D, Ye F, Lu W, Hu Y, Wan X, Chen Y and Xie X: Methylation status of the long control region of HPV 16 in clinical cervical specimens. Mol Med Rep 1: 555-560, 2008
APA
Hong, D., Ye, F., Lu, W., Hu, Y., Wan, X., Chen, Y., & Xie, X. (2008). Methylation status of the long control region of HPV 16 in clinical cervical specimens. Molecular Medicine Reports, 1, 555-560. https://doi.org/10.3892/mmr.1.4.555
MLA
Hong, D., Ye, F., Lu, W., Hu, Y., Wan, X., Chen, Y., Xie, X."Methylation status of the long control region of HPV 16 in clinical cervical specimens". Molecular Medicine Reports 1.4 (2008): 555-560.
Chicago
Hong, D., Ye, F., Lu, W., Hu, Y., Wan, X., Chen, Y., Xie, X."Methylation status of the long control region of HPV 16 in clinical cervical specimens". Molecular Medicine Reports 1, no. 4 (2008): 555-560. https://doi.org/10.3892/mmr.1.4.555